Esperion Therapeutics | Des Atouts



Assets Changement Date
AbbVie USD 135.16B 8.26B 2024-12
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amarin USD 655.68M 29.67M 2025-03
Amgen USD 89.37B 2.47B 2025-03
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Cipla INR 373.87B 27.32B 2025-03
CSL USD 38.45B 425M 2024-12
Cytokinetics USD 1.26B 137.62M 2025-03
Daiichi Sankyo JPY 3.46T 12.51B 2025-03
Eli Lilly USD 89.39B 10.67B 2025-03
Geron USD 562.45M 31.33M 2025-03
Grifols EUR 21.41B 1.12B 2024-12
Halozyme Therapeutics USD 2.2B 133.06M 2025-03
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
Merck USD 115.12B 1.98B 2025-03
Moderna USD 12.7B 1.44B 2025-03
Pfizer USD 208.03B 5.37B 2025-03
PTC Therapeutics USD 2.66B 950.36M 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Sanofi 131.89B 906M 2025-03
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
United Therapeutics USD 7.74B 379.9M 2025-03



Esperion Therapeutics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.